Cargando…
Quality of anticoagulant therapy and the incidence of in‐stent thrombosis after venous stenting
BACKGROUND: In patients with a venous outflow obstruction following iliofemoral deep vein thrombosis stenting of the venous tract to prevent or alleviate postthrombotic syndrome is applied with increasing frequency. The impact of the quality of anticoagulant therapy with vitamin K antagonists (VKAs)...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292674/ https://www.ncbi.nlm.nih.gov/pubmed/32548558 http://dx.doi.org/10.1002/rth2.12330 |
_version_ | 1783546156146491392 |
---|---|
author | Notten, Pascale van Laanen, Jorinde H. H. Eijgenraam, Pieter de Wolf, Mark A. F. Kurstjens, Ralph L. M. ten Cate, Hugo ten Cate‐Hoek, Arina J. |
author_facet | Notten, Pascale van Laanen, Jorinde H. H. Eijgenraam, Pieter de Wolf, Mark A. F. Kurstjens, Ralph L. M. ten Cate, Hugo ten Cate‐Hoek, Arina J. |
author_sort | Notten, Pascale |
collection | PubMed |
description | BACKGROUND: In patients with a venous outflow obstruction following iliofemoral deep vein thrombosis stenting of the venous tract to prevent or alleviate postthrombotic syndrome is applied with increasing frequency. The impact of the quality of anticoagulant therapy with vitamin K antagonists (VKAs) on the development of in‐stent thrombosis is currently unknown. OBJECTIVES: To determine the association between the quality of postinterventional VKA treatment and the occurrence of in‐stent thrombosis. METHODS: Seventy‐nine patients with iliofemoral and/or caval venous stent placement for obstruction of the venous outflow were included in this study. All patients received postinterventional VKA. The quality of VKA anticoagulant therapy was expressed as the time within therapeutic range (TTR) calculated using the linear interpolation method and as the proportion of International Normalized Ratio (INR) values < 2.0. In‐stent thrombosis was assessed by the use of duplex ultrasound. Survival analysis (Kaplan‐Meier curves, Cox regression) was used to analyze the data. RESULTS: In‐stent thrombosis developed in 16 patients (20.3%). The total population had a mean TTR of 64.0% (±19.0) and a mean proportion of INR values < 2.0 of 11.6% (±12.0). Overall, a TTR < 49.9% was associated with an increased risk of in‐stent thrombosis. The multivariable adjusted analysis showed a hazard ratio (HR) of 0.96 (95% confidence interval [CI], 0.92‐0.99; P = .02) per 1% increase in TTR. The proportion of INR values < 2.0 had no significant association with the occurrence of in‐stent thrombosis: HR 0.98 (95% CI, 0.91‐1.06; P = .66). CONCLUSIONS: We conclude that the quality of anticoagulant treatment reflected in the TTR following a venous stenting procedure is an important independent determinant for the risk of in‐stent thrombosis. The role of anticoagulant treatment for the prevention of in‐stent thrombosis following stenting procedures therefore merits further research. |
format | Online Article Text |
id | pubmed-7292674 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-72926742020-06-15 Quality of anticoagulant therapy and the incidence of in‐stent thrombosis after venous stenting Notten, Pascale van Laanen, Jorinde H. H. Eijgenraam, Pieter de Wolf, Mark A. F. Kurstjens, Ralph L. M. ten Cate, Hugo ten Cate‐Hoek, Arina J. Res Pract Thromb Haemost Original Article: Thrombosis BACKGROUND: In patients with a venous outflow obstruction following iliofemoral deep vein thrombosis stenting of the venous tract to prevent or alleviate postthrombotic syndrome is applied with increasing frequency. The impact of the quality of anticoagulant therapy with vitamin K antagonists (VKAs) on the development of in‐stent thrombosis is currently unknown. OBJECTIVES: To determine the association between the quality of postinterventional VKA treatment and the occurrence of in‐stent thrombosis. METHODS: Seventy‐nine patients with iliofemoral and/or caval venous stent placement for obstruction of the venous outflow were included in this study. All patients received postinterventional VKA. The quality of VKA anticoagulant therapy was expressed as the time within therapeutic range (TTR) calculated using the linear interpolation method and as the proportion of International Normalized Ratio (INR) values < 2.0. In‐stent thrombosis was assessed by the use of duplex ultrasound. Survival analysis (Kaplan‐Meier curves, Cox regression) was used to analyze the data. RESULTS: In‐stent thrombosis developed in 16 patients (20.3%). The total population had a mean TTR of 64.0% (±19.0) and a mean proportion of INR values < 2.0 of 11.6% (±12.0). Overall, a TTR < 49.9% was associated with an increased risk of in‐stent thrombosis. The multivariable adjusted analysis showed a hazard ratio (HR) of 0.96 (95% confidence interval [CI], 0.92‐0.99; P = .02) per 1% increase in TTR. The proportion of INR values < 2.0 had no significant association with the occurrence of in‐stent thrombosis: HR 0.98 (95% CI, 0.91‐1.06; P = .66). CONCLUSIONS: We conclude that the quality of anticoagulant treatment reflected in the TTR following a venous stenting procedure is an important independent determinant for the risk of in‐stent thrombosis. The role of anticoagulant treatment for the prevention of in‐stent thrombosis following stenting procedures therefore merits further research. John Wiley and Sons Inc. 2020-04-08 /pmc/articles/PMC7292674/ /pubmed/32548558 http://dx.doi.org/10.1002/rth2.12330 Text en © 2020 The Authors. Research and Practice in Thrombosis and Haemostasis published by Wiley Periodicals, Inc on behalf of International Society on Thrombosis and Haemostasis. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Article: Thrombosis Notten, Pascale van Laanen, Jorinde H. H. Eijgenraam, Pieter de Wolf, Mark A. F. Kurstjens, Ralph L. M. ten Cate, Hugo ten Cate‐Hoek, Arina J. Quality of anticoagulant therapy and the incidence of in‐stent thrombosis after venous stenting |
title | Quality of anticoagulant therapy and the incidence of in‐stent thrombosis after venous stenting |
title_full | Quality of anticoagulant therapy and the incidence of in‐stent thrombosis after venous stenting |
title_fullStr | Quality of anticoagulant therapy and the incidence of in‐stent thrombosis after venous stenting |
title_full_unstemmed | Quality of anticoagulant therapy and the incidence of in‐stent thrombosis after venous stenting |
title_short | Quality of anticoagulant therapy and the incidence of in‐stent thrombosis after venous stenting |
title_sort | quality of anticoagulant therapy and the incidence of in‐stent thrombosis after venous stenting |
topic | Original Article: Thrombosis |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292674/ https://www.ncbi.nlm.nih.gov/pubmed/32548558 http://dx.doi.org/10.1002/rth2.12330 |
work_keys_str_mv | AT nottenpascale qualityofanticoagulanttherapyandtheincidenceofinstentthrombosisaftervenousstenting AT vanlaanenjorindehh qualityofanticoagulanttherapyandtheincidenceofinstentthrombosisaftervenousstenting AT eijgenraampieter qualityofanticoagulanttherapyandtheincidenceofinstentthrombosisaftervenousstenting AT dewolfmarkaf qualityofanticoagulanttherapyandtheincidenceofinstentthrombosisaftervenousstenting AT kurstjensralphlm qualityofanticoagulanttherapyandtheincidenceofinstentthrombosisaftervenousstenting AT tencatehugo qualityofanticoagulanttherapyandtheincidenceofinstentthrombosisaftervenousstenting AT tencatehoekarinaj qualityofanticoagulanttherapyandtheincidenceofinstentthrombosisaftervenousstenting |